Artigos

Search for articles

BJO Oncology - Placeholder

Gastric Cancer: Molecular Characterization, Therapeutic Innovations, and Perspectives

Abstract Introduction Gastric cancer is the fifth most common neoplasm and the fourth leading cause of cancer-related death in the world. The present review aims to offer to the oncologic community the molecular characterization of gastric cancer, the therapeutic innovations and the perspectives for the systemic therapy for gastric cancer. Materials...
BJO Oncology - Placeholder

Second Opinion in Medical Oncology in the Age of Artificial Intelligence and Telemedicine

Abstract The present review explores the role and impact of second opinions in medical oncology, particularly considering the recent advancements in artificial intelligence (AI) and telemedicine. A comprehensive literature search was conducted, and data from various studies were analyzed, highlighting why patients seek a second opinion, the rates of disagreement...
BJO Oncology - Placeholder

From Data to Manuscript: A Strategy for Young Oncologists to Write a Scientific Paper

Abstract Scientific manuscripts are the basis for the transmission of scientific data among physicians in all fields of medicine. To teach young oncologists the skills needed to author a paper, we decided to emulate how experienced clinicians perform this task. The first step is to create a spreadsheet with all...
BJO Oncology - Placeholder

Gastrointestinal stromal tumors: advances in molecular characterization and therapeutic implications

ABSTRACT Recognition of the molecular basis of gastrointestinal stromal tumors has paved the way for significant breakthroughs in the diagnosis and treatment of this disease as well as positioned gastrointestinal stromal tumors as a framework for the concept of precision oncology in solid tumors. The incorporation of novel targeted agents...
BJO Oncology - Placeholder

Borderline ovarian tumors: a review of its biology, molecular profile, and management

ABSTRACT Borderline ovarian tumors typically exhibit indolent behavior and boast a favorable prognosis; however, a subset of patients experiences disease recurrence and progression to low-grade ovarian carcinoma. The complex biology underlying these phenomena has been illuminated through molecular analyses. KRAS and BRAF mutations have emerged as recurrent findings in borderline...
BJO Oncology - Placeholder

Preventive and therapeutic assessment program for mucositis in patients with cancer: promising advances in stomatological care

ABSTRACT Objectives: We propose a preventive and therapeutic assessment program for mucositis in patients with cancer based on a comprehensive review of scientific evidence. Material and Methods: This methodological study, designed as a non-systematic review, entails a thorough review of the scientific evidence on the management of mucositis in patients...
BJO Oncology - Placeholder

Use of CAR-T cells for the treatment of relapsed and refractory multiple myeloma: a systematic review

ABSTRACT A systematic review of published articles based on randomized clinical trials was conducted to ascertain the efficacy or perspective of using CAR-T cell therapy for refractory multiple myeloma. The PubMed database was searched with the combination of terms “multiple myeloma”, “refractory multiple myeloma”, “CAR T-cell”, and the PRISMA criteria...
BJO Oncology - Placeholder

PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil

ABSTRACT To report consensus recommendations on the current role of poly(ADP-ribose) polymerase (PARP) inhibitors in the front-line management of patients with epithelial ovarian cancer (EOC) in the healthcare setting of Brazil. The expert panel convened in March 2021 and comprised 20 medical oncologists focus on gynecological oncology. The panel answered...
BJO Oncology - Placeholder

Key issues in the management of cervical cancer: consensus recommendations by a Brazilian expert panel

ABSTRACT Objective: We report the results of a panel of Brazilian experts and provide recommendations for the management of these patients. Material and Methods: The panel convened composed by 28 local opinion leaders, addressed 59 multiple-choice questions taking into account the published scientific literature and their own clinical experience. The...
BJO Oncology - Placeholder

Personalized medicine: overview and comparison of challenges and opportunities for its implementation in the Brazilian public healthcare system (SUS)

ABSTRACT The objective of this work is, through a literature review, to promote the debate on personalized medicine and acquire a broad view of the subject and its tools from the perspective of oncology, disseminate the topic, support, and encourage initiatives to implement its technologies in the Brazilian public healthcare...